Sawai Group Holdings Co., Ltd. (TYO:4887)
Japan
· Delayed Price · Currency is JPY 2,155.00
-64.50 (-2.91%)
At close: Mar 9, 2026
Sawai Group Holdings Revenue
Sawai Group Holdings had revenue of 56.02B JPY in the quarter ending December 31, 2025, with 1.23% growth. This brings the company's revenue in the last twelve months to 200.68B, up 9.06% year-over-year. In the fiscal year ending March 31, 2025, Sawai Group Holdings had annual revenue of 189.02B with 6.88% growth.
Revenue (ttm)
200.68B
Revenue Growth
+9.06%
P/S Ratio
1.24
Revenue / Employee
60.63M
Employees
3,310
Market Cap
248.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 189.02B | 12.16B | 6.88% |
| Mar 31, 2024 | 176.86B | -23.48B | -11.72% |
| Mar 31, 2023 | 200.34B | 6.53B | 3.37% |
| Mar 31, 2022 | 193.82B | 6.60B | 3.52% |
| Mar 31, 2021 | 187.22B | 4.68B | 2.56% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tsumura & Co. | 189.50B |
| Toho Holdings | 1,539.60B |
| Towa Pharmaceutical | 269.92B |
| Nippon Shinyaku | 166.05B |
| Kissei Pharmaceutical | 95.29B |
| Kaken Pharmaceutical | 75.66B |
| Hisamitsu Pharmaceutical Co. | 159.27B |
| Mochida Pharmaceutical | 111.92B |